Testing conducted by Valisure LLC that found elevated levels of benzene in body spray products – the basis for its call for US Food and Drug Administration regulatory action – is potentially flawed and misrepresented, according to the Personal Care Products Council.
In comments filed with the agency on 9 November, PCPC raises questions about the New Haven, CT-based laboratory’s methodology, validation and use of good laboratory practices and says if...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?